# ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank

> **NCT06162546** · — · RECRUITING · sponsor: **Christoph Aufricht** · enrollment: 100 (estimated)

## Conditions studied

- Focal Segmental Glomerulosclerosis
- Proteinuria
- Nephrotic Syndrome
- Nephrotic Syndrome Steroid-Resistant

## Interventions

- **OTHER:** Registry

## Key facts

- **NCT ID:** NCT06162546
- **Lead sponsor:** Christoph Aufricht
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2033-12-31
- **Final completion:** 2033-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06162546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06162546, "ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06162546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*